O. Maillot, V. Atallah, F. Amestoy, N. Leduc, E. Gérard, A. Huchet, M. Beylot-Barry, C. Dupin, S. Prey, L. Dousset, N. Ouabrache, M. Martin, P. Gillon, C. Dutriaux, R. Trouette, V. Vendrely
{"title":"回顾性评估放射治疗对一线ipilimumab治疗的未突变BRAF表达转移性黑色素瘤患者的影响","authors":"O. Maillot, V. Atallah, F. Amestoy, N. Leduc, E. Gérard, A. Huchet, M. Beylot-Barry, C. Dupin, S. Prey, L. Dousset, N. Ouabrache, M. Martin, P. Gillon, C. Dutriaux, R. Trouette, V. Vendrely","doi":"10.1016/J.CANRAD.2018.07.121","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":414877,"journal":{"name":"Cancer/Radiothérapie","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Évaluation rétrospective de l’impact de la radiothérapie chez des patients atteints d’un mélanome métastatique exprimant BRAF non muté traités par ipilimumab en première ligne\",\"authors\":\"O. Maillot, V. Atallah, F. Amestoy, N. Leduc, E. Gérard, A. Huchet, M. Beylot-Barry, C. Dupin, S. Prey, L. Dousset, N. Ouabrache, M. Martin, P. Gillon, C. Dutriaux, R. Trouette, V. Vendrely\",\"doi\":\"10.1016/J.CANRAD.2018.07.121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":414877,\"journal\":{\"name\":\"Cancer/Radiothérapie\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer/Radiothérapie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.CANRAD.2018.07.121\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer/Radiothérapie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.CANRAD.2018.07.121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Évaluation rétrospective de l’impact de la radiothérapie chez des patients atteints d’un mélanome métastatique exprimant BRAF non muté traités par ipilimumab en première ligne